These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38938561)

  • 21. Anti-C1q antibodies, sCD40L, TWEAK and CD4/CD8 ratio in systemic lupus erythematosus and their relations to disease activity and renal involvement.
    ElGendi SS; El-Sherif WT
    Egypt J Immunol; 2009; 16(1):135-48. PubMed ID: 20726330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis.
    Moroni G; Radice A; Giammarresi G; Quaglini S; Gallelli B; Leoni A; Li Vecchi M; Messa P; Sinico RA
    Ann Rheum Dis; 2009 Feb; 68(2):234-7. PubMed ID: 18718989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cut-off values of immunological tests to identify patients at high risk of severe lupus nephritis.
    Gargiulo MLÁ; Khoury M; Gómez G; Grimaudo S; Suárez L; Collado MV; Sarano J
    Medicina (B Aires); 2018; 78(5):329-335. PubMed ID: 30285925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus.
    Moura CG; Mangueira CL; Cruz LA; Cruz CM
    Nephron Clin Pract; 2011; 118(4):c355-60. PubMed ID: 21325866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis.
    Tan Y; Song D; Wu LH; Yu F; Zhao MH
    BMC Nephrol; 2013 Mar; 14():63. PubMed ID: 23510032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H
    Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers.
    Akhter E; Burlingame RW; Seaman AL; Magder L; Petri M
    Lupus; 2011 Oct; 20(12):1267-74. PubMed ID: 21813587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-C1q in systemic lupus erythematosus.
    Stojan G; Petri M
    Lupus; 2016 Jul; 25(8):873-7. PubMed ID: 27252264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus.
    Siegert C; Daha M; Westedt ML; van der Voort E; Breedveld F
    J Rheumatol; 1991 Feb; 18(2):230-4. PubMed ID: 2023216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of a commercial kit for detecting anti-C1q autoantibodies and correlation with immunological and clinical activity of lupus nephritis.
    de Liso F; Matinato C; Novembrino C; Radice A; Raffiotta F; Ronchi M; Croci MD; Sinico RA; Messa P; Torresani E; Moroni G
    Clin Chem Lab Med; 2015 Oct; 53(11):1771-7. PubMed ID: 25870967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lupus nephritis sera contain autoantibodies that recognize epitopes within the globular fragment of C1q.
    Deliyska B; Tsacheva I; Radanova M; Stoianova V; Tchorbadjieva M; Dobreva N
    Med Pregl; 2007; 60 Suppl 2():25-7. PubMed ID: 18928152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
    Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
    Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares.
    Matrat A; Veysseyre-Balter C; Trolliet P; Villar E; Dijoud F; Bienvenu J; Fabien N
    Lupus; 2011 Jan; 20(1):28-34. PubMed ID: 20943718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of Anti-C1q Antibodies in Patients with Systemic Lupus Erythematosus as A Marker of Disease Activity and Lupus Nephritis.
    Soliman AF; Egailla SE; Abdel-Gawad ER; Mansour AI; ElKhouly TH; Mahgoub MY
    Egypt J Immunol; 2016 Jan; 23(1):107-116. PubMed ID: 28502158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of anti-nuclesome and anti C1q antibodies with lupus nephritis in an Egyptian cohort of patients with systemic lupus erythematosus.
    Metwally IM; Eesa NN; Yacoub MH; Elsman RM
    Adv Rheumatol; 2019 Mar; 59(1):10. PubMed ID: 30832710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus.
    Meyer OC; Nicaise-Roland P; Cadoudal N; Grootenboer-Mignot S; Palazzo E; Hayem G; Dieudé P; Chollet-Martin S
    Arthritis Res Ther; 2009; 11(3):R87. PubMed ID: 19515233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis--a hypothesis.
    Flierman R; Daha MR
    Mol Immunol; 2007 Jan; 44(1-3):133-8. PubMed ID: 16870257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.